Multi-Year Contracts With Public Schools And Hospitals Will Expand Markets

Key Takeaways

• Expansion into large public sector contracts and direct subscription models is driving recurring revenue growth and improving customer relationships.
  
• Operational efficiencies and resolved legal issues are enhancing profitability, cash flow, and long-term earnings visibility.
  
• Heavy upfront costs, operational risks, and ongoing legal concerns threaten profitability despite growth opportunities and reliance on increasing demand for physical security solutions.

Catalysts

Provides artificial intelligence (AI)-based weapons detection for security screening in the United States and internationally.

• The increasing prevalence of large multi-year contracts with public school systems and hospitals-driven by heightened public safety concerns in high-density environments-is expanding Evolv's total addressable market and should support outsized revenue growth over the coming years.
  
• Growing customer adoption and frequent upgrades to newer platforms like Gen2 and eXpedite reflect a successful technology road map that is boosting customer retention rates and fostering longer-term subscription commitments, positively impacting both ARR and net margins.
  
• The company's pivot away from channel/distribution sales to more direct subscription and direct purchase models raises ARR per unit and enhances customer relationships, which should drive higher recurring revenues, improved gross profit dollars, and greater pricing power over time.
  
• Recent operational improvements-such as reduced cost structure, tighter inventory management, and streamlined field service delivery-support improved operating leverage and margin expansion, which is likely to drive better earnings and positive cash flow.
  
• The settlement of legal and regulatory matters (e.g., termination of the DOJ investigation and cost-minimized class action settlement) removes overhangs, allowing management to focus entirely on execution and market expansion, which should lead to greater revenue predictability and stronger long-term earnings prospects.

Evolv Technologies Holdings Future Earnings and Revenue Growth

Assumptions

• Analysts are assuming Evolv Technologies Holdings's revenue will grow by 17.6% annually over the next 3 years.
• Analysts are not forecasting that Evolv Technologies Holdings will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Evolv Technologies Holdings's profit margin will increase from -39.1% to the average US Electronic industry of 9.0% in 3 years.
• If Evolv Technologies Holdings's profit margin were to converge on the industry average, you could expect earnings to reach $16.5 million (and earnings per share of $0.09) by about August 2028, up from $-44.4 million today. The analysts are largely in agreement about this estimate.
• In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 101.0x on those 2028 earnings, up from -27.2x today. This future PE is greater than the current PE for the US Electronic industry at 24.2x.
• Analysts expect the number of shares outstanding to grow by 4.09% per year for the next 3 years.
• To value all of this in today's terms, we will use a discount rate of 8.12%, as per the Simply Wall St company report.

Evolv Technologies Holdings Future Earnings Per Share Growth

Risks

• The company's shift from distribution to direct purchase fulfillment is expected to drive lower gross margins in the near term, due both to having to absorb the full cost of hardware up front and early ramping of new products (like eXpedite) that have not yet reached cost efficiency, which could pressure reported profitability and gross margin rates in upcoming quarters.
  
• While the company highlights new verticals and growing deployments, its current customer base is still relatively small compared to the total addressable market, and future growth depends heavily on continued successful expansion and retention across key verticals (e.g., education, healthcare, sports/entertainment); any slowdown or misexecution here could significantly impact revenue growth and future earnings.
  
• Despite recent stabilization, Evolv's financials show only modest positive cash flow and adjusted EBITDA, while operating profitability is still low single-digit; ongoing needs for R&D, customer support, and scaling field services could keep operating expenses high and limit meaningful improvements in net margins over the long term.
  
• The company's recent completion of a DOJ investigation and class action lawsuit settlement removes some overhangs, but the presence of litigation risks and past regulatory scrutiny highlight vulnerability to future legal or compliance challenges, any of which could lead to unexpected costs or reputational damage impacting earnings.
  
• The company's growth story relies heavily on the secular trend of physical site security demand, but secular risks-including shifts towards remote work or online events (reducing demand for physical security), increasing privacy and data security regulation (potential restrictions on AI-based screening), and supply chain challenges associated with hardware-could negatively affect both top-line growth and long-term profitability.

Valuation

• The analysts have a consensus price target of $7.188 for Evolv Technologies Holdings based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $8.25, and the most bearish reporting a price target of just $5.5.
  
• In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $184.7 million, earnings will come to $16.5 million, and it would be trading on a PE ratio of 101.0x, assuming you use a discount rate of 8.1%.
  
• Given the current share price of $7.37, the analyst price target of $7.19 is 2.5% lower. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
  
• We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.